SOP for Conducting Stability Studies for Injectable Products per ICH Guidelines

Guidelines for Stability Testing of Injectable Products as per ICH Guidelines

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for injectable drug products in accordance with the International Council for Harmonisation (ICH) guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of injectable products throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for injectable drug products intended for global markets.

3) Responsibilities

Stability Testing Team: Responsible for conducting stability studies and documenting results in compliance with ICH guidelines.

Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.

Regulatory Affairs Team: Responsible for ensuring that stability studies meet the regulatory expectations of target markets.

4) Procedure

4.1 Preparation for Stability Testing

4.1.1 Obtain and review the latest

ICH guidelines for stability testing of injectable products.

4.1.2 Develop a stability protocol specific to injectable products, including study design, testing schedule, storage conditions, and testing parameters as per ICH guidelines.

4.2 Selection of Batches and Samples

4.2.1 Select representative batches of the injectable product, typically three primary batches manufactured using the proposed production process.

4.2.2

Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.

4.3 Defining Storage Conditions and Time Points

4.3.1 Define the storage conditions according to ICH guidelines, typically including:

Long-term stability: 25°C ± 2°C/60% RH ± 5% RH
Accelerated stability: 40°C ± 2°C/75% RH ± 5% RH

4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.

4.4 Conducting Stability Tests

4.4.1 Store samples under the defined conditions, ensuring sterility and monitoring temperature and humidity as required.

4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including sterility, endotoxin levels, particulate matter, pH, and physical-chemical tests.

4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.

5) Abbreviations, if any

ICH: International Council for Harmonisation
QA: Quality Assurance
RH: Relative Humidity

6) Documents, if any

Stability protocol, stability data sheets, stability testing records, stability report, submission package to regulatory authorities.

7) Reference, if any

ICH Guidelines on Stability Testing of New Drug Substances and Products.

8) SOP Version

Version 1.0